| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Anna M Becker, Friederike Holze, Tanja Grandinetti, Aaron Klaiber, Vanja E Toedtli, Karolina E Kolaczynska, Urs Duthaler, Nimmy Varghese, Anne Eckert, Edna Grünblatt, Matthias E Liecht. Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects. Clinical pharmacology and therapeutics. 2021-11-22. PMID:34743319. |
the psychedelic psilocybin is being investigated for the treatment of depression and anxiety. |
2021-11-22 |
2023-08-13 |
human |
| Susan Ling, Felicia Ceban, Leanna M W Lui, Yena Lee, Kayla M Teopiz, Nelson B Rodrigues, Orly Lipsitz, Hartej Gill, Mehala Subramaniapillai, Rodrigo B Mansur, Kangguang Lin, Roger Ho, Joshua D Rosenblat, David Castle, Roger S McIntyr. Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression. CNS drugs. 2021-11-18. PMID:34791625. |
molecular mechanisms of psilocybin and implications for the treatment of depression. |
2021-11-18 |
2023-08-13 |
Not clear |
| Nan-Xi Li, Yi-Ru Hu, Wang-Ni Chen, Bin Zhan. Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis. Journal of affective disorders. vol 296. 2021-11-15. PMID:34587546. |
dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis. |
2021-11-15 |
2023-08-13 |
Not clear |
| Nan-Xi Li, Yi-Ru Hu, Wang-Ni Chen, Bin Zhan. Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis. Journal of affective disorders. vol 296. 2021-11-15. PMID:34587546. |
in the current study, we aim to explore the dose effects of psilocybin on primary (major depression patients) and secondary depression (depressed cancer patients). |
2021-11-15 |
2023-08-13 |
Not clear |
| Flora Graha. Daily briefing: Largest trial shows psilocybin is effective to treat depression. Nature. 2021-11-12. PMID:34764467. |
daily briefing: largest trial shows psilocybin is effective to treat depression. |
2021-11-12 |
2023-08-13 |
Not clear |
| Lea J Mertens, Katrin H Prelle. Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders. Pharmacopsychiatry. vol 54. issue 4. 2021-10-28. PMID:33472250. |
modern clinical research is currently gaining momentum and provides new evidence for the safety and efficacy of classical psychedelics (primarily psilocybin, but also lsd and ayahuasca) in the treatment of different psychiatric conditions, including substance use and mood disorders.in this review article, we outline common pathological mechanisms of substance use disorders (sud) and unipolar depression. |
2021-10-28 |
2023-08-13 |
human |
| Sandeep M Nayak, Natalie Gukasyan, Frederick S Barrett, Earth Erowid, Fire Erowid, Roland R Griffith. Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports. Pharmacopsychiatry. vol 54. issue 5. 2021-10-28. PMID:34348413. |
this is important to know, as individuals with bipolar depression may attempt to treat themselves with psychedelics while on a mood stabilizer, particularly given enthusiastic media reports of the efficacy of psilocybin for depression. |
2021-10-28 |
2023-08-13 |
Not clear |
| Teresa Kay Jones, Steven Lippman. Psilocybin Can Diminish Depression. The primary care companion for CNS disorders. vol 22. issue 5. 2021-10-15. PMID:32898345. |
psilocybin can diminish depression. |
2021-10-15 |
2023-08-13 |
Not clear |
| Igor Magaraggia, Zilla Kuiperes, Rudy Schreibe. Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach. Neurobiology of learning and memory. vol 183. 2021-09-22. PMID:34048913. |
at the psychobiological level, we hypothesize that the negativity bias in mdd is due to impaired pattern separation and that psychedelics such as psilocybin help in depression because they enhance pattern separation and hence reduce negativity bias. |
2021-09-22 |
2023-08-13 |
Not clear |
| Joshua F Wiley, Bei Be. Psilocybin for Depression. The New England journal of medicine. vol 385. issue 9. 2021-09-06. PMID:34437794. |
psilocybin for depression. |
2021-09-06 |
2023-08-13 |
Not clear |
| Iain Jorda. Psilocybin for Depression. The New England journal of medicine. vol 385. issue 9. 2021-09-06. PMID:34437795. |
psilocybin for depression. |
2021-09-06 |
2023-08-13 |
Not clear |
| Fredrik Hieronymus, Søren D Østergaar. Psilocybin for Depression. The New England journal of medicine. vol 385. issue 9. 2021-09-06. PMID:34437796. |
psilocybin for depression. |
2021-09-06 |
2023-08-13 |
Not clear |
| Gerhard Gründer, Lea Merten. Psilocybin for Depression. The New England journal of medicine. vol 385. issue 9. 2021-09-06. PMID:34437797. |
psilocybin for depression. |
2021-09-06 |
2023-08-13 |
Not clear |
| Robin Carhart-Harris, Allan Blemings, David J Nut. Psilocybin for Depression. Reply. The New England journal of medicine. vol 385. issue 9. 2021-09-06. PMID:34437798. |
psilocybin for depression. |
2021-09-06 |
2023-08-13 |
Not clear |
| Dominika Psiuk, Emilia Nowak, Krystian Cholewa, Urszula Łopuszańska, Marzena Samardakiewic. The Potential Role of Serotonergic Hallucinogens in Depression Treatment. Life (Basel, Switzerland). vol 11. issue 8. 2021-08-31. PMID:34440508. |
a literature search of the pubmed/medline database identified 14 clinical trials from the last 10 years that examined the use of psilocybin, mdma, dmt, or lsd for the treatment of depression symptoms. |
2021-08-31 |
2023-08-13 |
Not clear |
| Dominika Psiuk, Emilia Nowak, Krystian Cholewa, Urszula Łopuszańska, Marzena Samardakiewic. The Potential Role of Serotonergic Hallucinogens in Depression Treatment. Life (Basel, Switzerland). vol 11. issue 8. 2021-08-31. PMID:34440508. |
moreover, one study revealed that psilocybin has comparable efficacy to escitalopram in the treatment of depression. |
2021-08-31 |
2023-08-13 |
Not clear |
| Gniewko Więckiewicz, Iga Stokłosa, Magdalena Piegza, Piotr Gorczyca, Robert Pudl. Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review. Pharmaceuticals (Basel, Switzerland). vol 14. issue 8. 2021-08-31. PMID:34451890. |
lysergic acid diethylamide, psilocybin and dimethyltryptamine in depression treatment: a systematic review. |
2021-08-31 |
2023-08-13 |
Not clear |
| Gniewko Więckiewicz, Iga Stokłosa, Magdalena Piegza, Piotr Gorczyca, Robert Pudl. Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review. Pharmaceuticals (Basel, Switzerland). vol 14. issue 8. 2021-08-31. PMID:34451890. |
the aim of this study was to evaluate the efficiency of lsd, psilocybin and dmt in depression treatment in the light of current medical literature. |
2021-08-31 |
2023-08-13 |
Not clear |
| Gniewko Więckiewicz, Iga Stokłosa, Magdalena Piegza, Piotr Gorczyca, Robert Pudl. Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review. Pharmaceuticals (Basel, Switzerland). vol 14. issue 8. 2021-08-31. PMID:34451890. |
most of the selected studies showed significant correlation between psilocybin and dmt use and reduction in depression symptom intensity. |
2021-08-31 |
2023-08-13 |
Not clear |
| Gniewko Więckiewicz, Iga Stokłosa, Magdalena Piegza, Piotr Gorczyca, Robert Pudl. Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review. Pharmaceuticals (Basel, Switzerland). vol 14. issue 8. 2021-08-31. PMID:34451890. |
by analyzing qualified studies, it can be concluded that psilocybin and dmt could be useful in depression treatment, but further observations are still required. |
2021-08-31 |
2023-08-13 |
Not clear |